Ahammune Biosciences, an Indian clinical-stage therapeutics company working on new ways to cure skin diseases, on Wednesday, said it has raised $5 million in a Series A round of funding led by early-stage deep tech-focused investor pi Ventures.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in